Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Blood-brain barrier dysfunction and inflammation linked to Down syndrome Regression Disorder

Blood-brain barrier dysfunction and inflammation linked to Down syndrome Regression Disorder

New scientific clue could unlock key cellular pathway leading to neurodegenerative diseases

New scientific clue could unlock key cellular pathway leading to neurodegenerative diseases

University of Minnesota awarded NIH grant for Alzheimer's cell therapy development

University of Minnesota awarded NIH grant for Alzheimer's cell therapy development

Bioenergetic age could predict Alzheimer's disease risk

Bioenergetic age could predict Alzheimer's disease risk

Groundbreaking stem cell therapy trial for Alzheimer's disease underway at UTHealth Houston

Groundbreaking stem cell therapy trial for Alzheimer's disease underway at UTHealth Houston

Portable system detects mild cognitive impairment in older adults

Portable system detects mild cognitive impairment in older adults

Study links Doomsday Clock to mortality and mental health

Study links Doomsday Clock to mortality and mental health

Dementia risk higher among adults with HIV in Malawi

Dementia risk higher among adults with HIV in Malawi

Compound found in rosemary shows promise for Alzheimer's treatment

Compound found in rosemary shows promise for Alzheimer's treatment

Understanding the role of LSD1 in cellular processes and disease

Understanding the role of LSD1 in cellular processes and disease

Music-based therapy may benefit people living with dementia

Music-based therapy may benefit people living with dementia

New brain mapping technique identifies cells vulnerable to Alzheimer's disease

New brain mapping technique identifies cells vulnerable to Alzheimer's disease

Study suggests boosting brain's immune cells could improve Alzheimer's treatment

Study suggests boosting brain's immune cells could improve Alzheimer's treatment

St. Jude researchers improve brain disease diagnosis with PET imaging and ALS drug

St. Jude researchers improve brain disease diagnosis with PET imaging and ALS drug

Menopausal hormone therapy may accelerate tau buildup in older women

Menopausal hormone therapy may accelerate tau buildup in older women

Higher menopausal symptom burden linked to cognitive decline and behavioral impairments

Higher menopausal symptom burden linked to cognitive decline and behavioral impairments

New approach to tau protein clearance offers hope for Alzheimer's treatment

New approach to tau protein clearance offers hope for Alzheimer's treatment

Exploring the role of subventricular zone in neural regeneration, neurodegenerative diseases

Exploring the role of subventricular zone in neural regeneration, neurodegenerative diseases

Study explores gene interactions in Alzheimer's disease across brain regions

Study explores gene interactions in Alzheimer's disease across brain regions

Non-invasive 40Hz gamma stimulation could help fight Alzheimer’s

Non-invasive 40Hz gamma stimulation could help fight Alzheimer’s

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.